Center for Applied Psychology, Miguel Hernández University, Avenida Universidad, s/n, Elche, Spain.
University General Hospital of Elche, Elche, Spain.
J Pain. 2022 Aug;23(8):1427-1436. doi: 10.1016/j.jpain.2022.03.236. Epub 2022 Apr 14.
Opioid withdrawal is characterized by a set of physical and psychological symptoms that depend on both opioid and patient specific characteristics. The present study aims to identify different latent classes of chronic pain patients according to the type of opioid withdrawal symptoms experienced, and to analyze the relationships between the classes and demographic, opioid therapy, psychological and substance use variables. This cross-sectional descriptive study included 391 chronic pain patients on long-term opioid therapy. A Latent Class Analysis (LCA) identified 3 classes (BIC = 7051.89, entropy = .87, LRTs P < .01). The mild withdrawal class showed low probabilities of presenting physical and psychological symptoms, the moderate withdrawal class was characterized by experiencing psychological symptoms, and the severe withdrawal class stood out for high probabilities of presenting both types of symptoms. The classes differed from each other, with higher rates of moderate-severe POUD, opioid misuse, anxiety, depression, and greater pain intensity and interference in more severe withdrawal classes (P < .05). The multinomial logistic regression showed that moderate-severe POUD and anxiety were the strongest variables related to moderate (OR = 3.34, OR = 2.58) and severe withdrawal classes (OR = 4.26, OR = 5.15). Considering that POUD and anxiety were strongly related to a more severe withdrawal syndrome, the inclusion of psychological interventions in pain management seems critical in this population. PERSPECTIVE: Although interdose opioid withdrawal is common in chronic pain patients, this study shows 3 different patterns in its experience (mild, moderate, and severe withdrawal). A more severe withdrawal may result in reduced effectiveness of opioids in relieving pain and increased negative consequences, such as higher risk of POUD. Findings that could help improve chronic pain management.
阿片类药物戒断的特征是一系列生理和心理症状,这些症状既取决于阿片类药物,也取决于患者的具体特征。本研究旨在根据经历的阿片类药物戒断症状类型,确定慢性疼痛患者的不同潜在类别,并分析这些类别与人口统计学、阿片类药物治疗、心理和物质使用变量之间的关系。这是一项横断面描述性研究,纳入了 391 名长期接受阿片类药物治疗的慢性疼痛患者。潜在类别分析(LCA)确定了 3 个类别(BIC=7051.89,熵=.87,LRTs P<.01)。轻度戒断组表现出出现身体和心理症状的可能性较低,中度戒断组以出现心理症状为特征,而重度戒断组则表现出出现两种类型症状的可能性较高。这些类别彼此不同,中度至重度 POUD、阿片类药物滥用、焦虑、抑郁的发生率较高,在更严重的戒断类别中疼痛强度和干扰更大(P<.05)。多变量逻辑回归显示,中度至重度 POUD 和焦虑是中度(OR=3.34,OR=2.58)和重度戒断类别的最强相关变量(OR=4.26,OR=5.15)。考虑到 POUD 和焦虑与更严重的戒断综合征密切相关,在疼痛管理中纳入心理干预措施似乎对该人群至关重要。观点:尽管慢性疼痛患者中存在阿片类药物戒断,但本研究显示其体验存在 3 种不同模式(轻度、中度和重度戒断)。更严重的戒断可能导致阿片类药物缓解疼痛的效果降低,并增加负面后果,如 POUD 风险增加。这些发现有助于改善慢性疼痛管理。